Search research articles
Contact Us
Filters
Showing results (41-50 of 103) with videos related to
Page
of 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
September 10, 2003
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens
Richard A Morgan, Mark E Dudley, Yik Y L Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2022
FDA Approval Summary: Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma
Andrea C Baines, Rachel Ershler, Bindu Kanapuru, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2023
FDA Oncology Center of Excellence Crowdsourcing Initiative: Outreach to the Scientific Community to Identify Research Questions for Pooled Analyses of Oncology Clinical Trial Data
Julie A Schneider, Julia Eckstein, Kirsten B Goldberg, et al.
The Oncologist
|
August 19, 2024
Treatment of Acute Myeloid Leukemia in the Community Setting
Taha Al-Juhaishi, Servillano Dela Cruz, Rohan Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2023
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Deepti Telaraja, Yvette L Kasamon, Justin S Collazo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2023
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation
Ashley Woods, Kelly J Norsworthy, Xin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2023
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective
Andrea C Baines, Maryam Sarraf Yazdy, Yvette L Kasamon, et al.
The Oncologist
|
May 11, 2021
FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with Sorafenib
May Tun Saung, Lorraine Pelosof, Sandra Casak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2020
FDA Approval Summary: Ado-Trastuzumab Emtansine for the Adjuvant Treatment of HER2-positive Early Breast Cancer
Suparna Wedam, Lola Fashoyin-Aje, Xin Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2022
FDA Approval Summary: Ripretinib for Advanced Gastrointestinal Stromal Tumor
Vaibhav Kumar, Leslie Doros, Margaret Thompson, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 103) with videos related to
Sort By:
Page
of 11
Journal of Immunology (Baltimore, Md. : 1950)
|
September 10, 2003
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens
Richard A Morgan, Mark E Dudley, Yik Y L Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 23, 2022
FDA Approval Summary: Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma
Andrea C Baines, Rachel Ershler, Bindu Kanapuru, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2023
FDA Oncology Center of Excellence Crowdsourcing Initiative: Outreach to the Scientific Community to Identify Research Questions for Pooled Analyses of Oncology Clinical Trial Data
Julie A Schneider, Julia Eckstein, Kirsten B Goldberg, et al.
The Oncologist
|
August 19, 2024
Treatment of Acute Myeloid Leukemia in the Community Setting
Taha Al-Juhaishi, Servillano Dela Cruz, Rohan Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2023
FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Deepti Telaraja, Yvette L Kasamon, Justin S Collazo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2023
FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation
Ashley Woods, Kelly J Norsworthy, Xin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2023
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective
Andrea C Baines, Maryam Sarraf Yazdy, Yvette L Kasamon, et al.
The Oncologist
|
May 11, 2021
FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with Sorafenib
May Tun Saung, Lorraine Pelosof, Sandra Casak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2020
FDA Approval Summary: Ado-Trastuzumab Emtansine for the Adjuvant Treatment of HER2-positive Early Breast Cancer
Suparna Wedam, Lola Fashoyin-Aje, Xin Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2022
FDA Approval Summary: Ripretinib for Advanced Gastrointestinal Stromal Tumor
Vaibhav Kumar, Leslie Doros, Margaret Thompson, et al.
Page
of 11